No shortage on file

NIASTASE RT

NOVO NORDISK CANADA INC

Quick answers

Is there a shortage of NIASTASE RT in Canada?

No. There is no current shortage of NIASTASE RT 1MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on file2 products

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

NIASTASE

NOVO NORDISK CANADA INC

1.2MG · DIN 02239659

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

NIASTASE RT

NOVO NORDISK CANADA INC

8MG · DIN 02365669

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

DIN

02417103

Strength

1MG

Dosage Form

Powder For Solution

Route

Intravenous

Active Ingredient

EPTACOG ALFA (ACTIVATED)

See all EPTACOG ALFA (ACTIVATED) products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

No shortage or discontinuation reports on file for this product.

Other Products from NOVO NORDISK CANADA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACTIVELLE

DIN 02249405

ACTIVELLE LD

DIN 02309009

AWIQLI

2100UNIT · DIN 02546221

AWIQLI

700UNIT · DIN 02546205

AWIQLI

1050UNIT · DIN 02546213

ESPEROCT

500UNIT · DIN 02490064